View all cases
- Case details
- Status—Action—CategoryOther procedural
- Parties
- Claimants
- Edwards Lifesciences CorporationOperating co.
Representatives- Boris Kreye-Bird & Bird LLP
- Siddharth Kusumakar-Powell Gilbert (Europe) LLP
- Bernhard Thum-Thum & Partner
- Tessa Waldron-Powell Gilbert (Europe) LLP
Respondents- Meril Italy srlOperating co.
Representatives- Emmanuel Larere-Cabinet Gide Loyrette Nouel AARPI
- Raphaëlle Dequiré-Portiersupporting-Cabinet Gide Loyrette Nouel AARPI
- Division
- —
- Technology
- InstrumentsMedical technology
- Language
- —
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Judge Paolo Catallozzi | Locked |
| Judge Tatyana Zhilova | Locked |
| Judge Stefan Wilhelm | Locked |
At the UPC: Edwards Lifesciences Group (57 cases)·Meril Group (60 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 6 other proceedings
UPC CoA 530/2024·UPC CoA 464/2024·UPC CFI 255/2023·CC 585030/2023·UPC APP 7184/2024 and 1 more
12 other defendants litigating the same or a related patent
UPC CFI 202/2025·UPC CoA 166/2025·UPC CoA 21/2025·UPC CoA 27/2025·UPC CFI 815/2024 and 7 more
Start a free trial to see how each one ended.
More cases: 2024
Decisions
- 2024-04-30
Summary: The Paris Central Division exercised its discretion to admit Edwards Lifesciences' subsequent request to amend patent EP 3 646 825 after the written procedure had closed, provided that Meril Italy was granted additional time to submit a defence to the new amendment, holding that such admission does not prejudice the opposing party's right of defence.
Show the legal issues (3)
- subsequent request to amend patent R.30(2) RoP
- court discretion after closure of written procedure
- right of defence
Documents
- 2024-04-30%20CD%20Paris%20UPC_CFI_255-2023%20-%20ORD_24620-2024%20App_19959-2024%20and%2023242-2024%20-%20anonymized.pdf2024-04-30EN